{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : true,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00493",
      "entity_text" : "COX-2 inhibitors",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P10145",
      "entity_text" : "IL-8",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In contrast, administration of IL-8 (or the rat analogue CINC-1) in peripheral tissues or intrathecally causes an increase in pain sensitivity that can be reversed by beta-adrenergic receptor antagonists or guanethidine but not COX-2 inhibitors, which fits well with the inefficacy of COX-2 inhibitors in FM.",
  "reading_complete" : "2020-07-28T14:07:11Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T14:05:34Z",
  "trigger" : "causes",
  "evidence" : [ "IL-8 (or the rat analogue CINC-1) in peripheral tissues or intrathecally causes an increase in pain sensitivity               that can be reversed by beta-adrenergic receptor antagonists               or guanethidine               but not COX-2 inhibitors" ],
  "pmc_id" : "4372266",
  "score" : 0
}